1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor
Motovska Z, Hlinomaz O, PRAGUE-18 Study Group et al.
KEYWORDS
myocardial infarction; outcome; prasugrel; primary percutaneous coronary intervention; switch; ticagrelor
BACKGROUND - Early outcomes of patients in the PRAGUE-18 (Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction) study did not find any significant differences between 2 potent P2Y12 inhibitors.